Effects of Protein Kinase Inhibitors on Tumor Cell Movement
Author Information
Author(s): A. Zimmermann, H. Keller
Primary Institution: Institute of Pathology, University of Bern
Hypothesis
Do protein kinase inhibitors affect the shape and movement of Walker carcinosarcoma cells?
Conclusion
Staurosporine and K 252a inhibit the movement and polarity of Walker carcinosarcoma cells, while CGP 41251 increases cell polarity and locomotion.
Supporting Evidence
- Staurosporine and K 252a suppress cell polarity and locomotion of Walker carcinosarcoma cells.
- CGP 41251, a staurosporine derivative, increases the proportion of polarized cells.
- Staurosporine inhibits spontaneous and colchicine-induced front-tail polarity.
Takeaway
This study found that certain drugs can change how cancer cells move and their shape, which might help in understanding how to control cancer spread.
Methodology
The study used in vitro experiments to analyze the effects of various protein kinase inhibitors on the shape and locomotion of Walker carcinosarcoma cells.
Limitations
The study may not fully represent the behavior of invasive human tumors as it was conducted in vitro.
Want to read the original?
Access the complete publication on the publisher's website